MOKAN Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.29M Buy
48,990
+6,048
+14% +$708K 2.41% 12
2026
Q1
$5.17M Sell
42,942
-3,213
-7% -$371K 2.29% 11
2025
Q4
$4.86M Sell
46,155
-4,785
-9% -$449K 2.16% 12
2025
Q3
$4.28M Sell
50,940
-8,449
-14% -$696K 2.15% 12
2025
Q2
$4.7M Buy
59,389
+14,568
+33% +$1.16M 2.63% 9
2025
Q1
$4.02M Buy
44,821
+5,426
+14% +$507K 2.42% 12
2024
Q4
$3.92M Buy
+39,395
New +$4.06M 2.49% 12

Other funds holding MRK

MOKAN Wealth Management's MRK Position: Q2 2026 in Review

MOKAN Wealth Management increased its Merck (MRK) stake by 14% in Q2 2026, buying an estimated $708K and bringing the position to 48,990 shares worth $6.29M. The position accounts for 2.41% of the portfolio, ranked #12.

MOKAN Wealth Management first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 1,880 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • MOKAN Wealth Management held 48,990 shares of Merck worth $6.29M as of Q2 2026.
  • MOKAN Wealth Management bought 6,048 Merck shares in Q2 2026, an estimated $708K.
  • Merck made up 2.41% of MOKAN Wealth Management's portfolio in Q2 2026, its #12 holding.
  • MOKAN Wealth Management first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 1,880 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on MOKAN Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.